<unk> , sold under the brand name Monoferric, is a medication for the treatment of iron deficiency anemia (IDA) in adults who have intolerance to oral iron or have had unsatisfactory response to oral iron or who have non-hemodialysis dependent chronic kidney disease (NDD-CKD). It was approved for use in the United States in January 2020. It is given intravenously.
Ferric derisomaltose
Thiamylal
Diatrizoate
Lactitol
Calcium fructoborate
Tricresyl phosphate
Sodium fluoroacetate
Sucrosomial iron